NASDAQ · Drug Manufacturers - Specialty & Generic

AMRX (AMRX) Stock

$17.68 +1.20% NASDAQ: AMRX Healthcare

Valuation

MetricValue
Price$17.68
Market Cap$5.65B
P/E Ratio36.56
P/B Ratio175.82
P/S Ratio1.86
EPS (TTM)$0.37
52-Week High$19.26
52-Week Low$9.20
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-326.75%
ROA4.17%
ROCE13.94%
Gross Margin39.17%
Operating Margin19.57%
Net Margin5.05%
Debt/Equity84.54
Current Ratio2.47

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.1B$2.2B$2.4B$2.8B$3.0B
Operating Profit$153.0M$-95.0M$204.0M$249.0M$423.0M
Net Profit$11.0M$-130.0M$-84.0M$-117.0M$72.0M
EPS$0.07$-0.86$-0.48$-0.38$0.22
Op Margin7.3%-4.3%8.5%8.9%14.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$3.9B$3.8B$3.5B$3.5B$3.7B
Total Liabilities$3.6B$3.6B$3.4B$3.5B$3.7B
Cash$248.0M$26.0M$92.0M$111.0M$311.0M
Borrowings$2.9B$2.8B$2.8B$2.6B$2.7B

Latest News

3 Reasons AMRX is Risky and 1 Stock to Buy Instead StockStory · Jul 15, 2026 AMRX: What does Argus have to say about AMRX? Argus Research · Jul 15, 2026 Amneal to Report Second Quarter 2026 Results on July 30, 2026 GlobeNewswire · Jul 9, 2026 Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers StockStory · Jul 7, 2026 Market Chatter: Eli Lilly, Regeneron Among First Companies in FDA PreCheck Pilot Program MT Newswires · Jun 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$242.0M$65.0M$346.0M$295.0M$340.0M
Investing Cash Flow$-242.0M$-265.0M$-138.0M$-138.0M$-182.0M
Financing Cash Flow$-60.0M$-68.0M$-235.0M$-27.0M$-60.0M
Net Cash Flow$-90.0M$-222.0M$64.0M$19.0M$195.0M
Free Cash Flow$194.0M$-25.0M$276.0M$220.0M$270.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA12.99
FCF Yield1.43%
Quick Ratio1.44
Interest Coverage1.77
Return 1Y83.66%
Return 3Y314.66%
Return 5Y239.89%

Ownership

Insiders Held49.04%
Institutions Held52.24%
Institutions Float Held102.50%
Institutional HolderSharesReport Date
Blackrock Inc.24,519,1922026-03-31
TPG GP A, LLC12,328,7672026-03-31
Vanguard Portfolio Management LLC11,324,9332026-03-31
Rubric Capital Management LP11,037,5892026-03-31
Vanguard Capital Management LLC7,585,0342026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BHC $6.47 +1.57% -2.21 $2.42B 0.00%
DYN $25.10 -1.30% -7.64 $4.69B 0.00%
INDV $34.56 -1.06% 12.61 $4.31B 0.00%
LNTH $100.88 -0.08% 27.24 $6.57B 0.00%
MIRM $98.34 +0.30% -6.69 $6.00B 0.00%

About AMRX

AMRX stock trades at $17.68 with a market capitalization of $5.65B. The stock is valued at a price-to-earnings (P/E) ratio of 36.56, price-to-book of 175.82, price-to-sales of 1.86. Over the past 52 weeks the stock has ranged between $9.20 and $19.26, and currently trades 8.2% below its 52-week high.

On profitability, AMRX generates a return on equity (ROE) of -326.75%, return on capital employed of 13.94%, an operating margin of 19.57%, a net profit margin of 5.05%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides